As of Jul 28
| +2.84 / +5.57%|
The 4 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 61.50, with a high estimate of 62.00 and a low estimate of 50.00. The median estimate represents a +14.29% increase from the last price of 53.81.
The current consensus among 4 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.